Sydenham's chorea

Last updated
Sydenham's chorea
Other namesRheumatic chorea, chorea minor, St Vitus' dance
Specialty Neurology   OOjs UI icon edit-ltr-progressive.svg

Sydenham's chorea, also known as rheumatic chorea, is a disorder characterized by rapid, uncoordinated jerking movements primarily affecting the face, hands and feet. [1] Sydenham's chorea is an autoimmune disease that results from childhood infection with Group A beta-haemolytic Streptococcus . It is reported to occur in 20–30% of people with acute rheumatic fever and is one of the major criteria for it, although it sometimes occurs in isolation. The disease occurs typically a few weeks, but up to 6 months, after the acute infection, which may have been a simple sore throat (pharyngitis).

Contents

Sydenham's chorea is more common in females than males, and most cases affect children between 5 and 15 years of age. Adult onset of Sydenham's chorea is comparatively rare, and the majority of the adult cases are recurrences following childhood Sydenham's chorea (although pregnancy [2] and female hormone treatment [3] are also potential causes).

It is historically one of the conditions called St Vitus' dance . [4]

Signs and symptoms

Sydenham's chorea is characterized by the abrupt onset (sometimes within a few hours) of neurological symptoms, classically chorea, which are non-rhythmic, writhing or explosive involuntary movements. Usually all four limbs are affected, but there are cases reported where just one side of the body is affected (hemichorea). Typical chorea includes repeated wrist hyperextension, grimacing, and lip pouting. The fingers can move as if playing the piano. There may be tongue fasciculations ("bag of worms") and motor impersistence, for example, the "milkmaid sign" (grip strength fluctuates, as if hand milking a cow), or inability to sustain tongue protrusion (called jack-in-the-box tongue [5] or serpentine tongue, [6] as the tongue slides in and out of the mouth), or eye closure.

There is usually a loss of fine motor control, which is particularly obvious in handwriting if the child is of school age. Speech is often affected (dysarthria), as is walking; legs will suddenly give way or flick out to one side, giving an irregular gait and the appearance of skipping or dancing. Underlying the abnormal movements is often low tone (hypotonia) which may not become obvious until treatment is started to suppress the chorea.

The severity of the condition can vary from just some instability on walking and difficulty with handwriting, to the extreme of being wholly unable to walk, talk, or eat (chorea paralytica).

Movements cease during sleep.

It is a neuropsychiatric disorder, so besides the motor problems there is classically emotional lability (mood swings, or inappropriate mood), but also tics, anxiety, attention deficit etc. These can precede the motor symptoms. [7]

Non-neurologic manifestations of acute rheumatic fever may be present, namely carditis (up to 70% of cases, often subclinical, so echocardiography required), arthritis, erythema marginatum, and subcutaneous nodules.

Erythema marginatum Erythema marginatum.jpg
Erythema marginatum

Differentiating these signs from other involuntary movements such as tics and stereotypies can be difficult, and since these things are not uncommon they can potentially co-exist. Diagnosis is often delayed and attributed to another condition such as tic disorder or conversion disorder. The controversial PANDAS (pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections) hypothesis has overlapping clinical features, but Sydenham's chorea is one of the exclusion criteria. PANDAS can present with chorea but more typically there are tics or stereotypies with a psychological component (e.g., OCD). [8] [9] [10]

Differential diagnosis

Other disorders that may be accompanied by chorea include benign hereditary chorea, bilateral striatal necrosis, abetalipoproteinemia, ataxia–telangiectasia, biotin-thiamine-responsive basal ganglia disease (BTBGD), Fahr disease, familial dyskinesia–facial myokymia (Bird–Raskind syndrome) due to an ADCY5 gene mutation, glutaric aciduria, Lesch–Nyhan syndrome, mitochondrial disorders, Huntington's disease, Wilson disease, hyperthyroidism, lupus erythematosus, pregnancy (chorea gravidarum), drug intoxication and side effects of certain anticonvulsants (e.g. phenytoin) or psychotropic agents. Although some of these can similarly present in an acute way, there will typically be other neurological signs (such as ataxia or cognitive impairment), or other disease manifestations, or positive family history, which will help distinguish between them. [11]

Pathology

One of the important manifestations of acute rheumatic fever, Sydenham's chorea is believed to be caused by an autoimmune response following infection by group A β-hemolytic streptococci. [12] [4]

Two cross-reactive streptococcal antigens have been identified, the M protein and N-acetyl-beta-D-glucosamine, whereby infection leads to autoantibodies being produced against host tissues (molecular mimicry) causing a variety of streptococcal related diseases including Sydenham's chorea but also rheumatic heart disease and nephritic syndrome. [13] Autoantibodies against basal ganglia proteins have been found in Sydenham's chorea but these are non-specific. [14] Dopamine receptor autoantibodies have been reported to correlate with clinical symptoms. [15] Whether these antibodies represent an epiphenomenon or are pathogenic, remains to be proven. [4]

Epidemiology

Sydenham's chorea is primarily seen in children. [4]

As with rheumatic fever, Sydenham's chorea is seen more often in less affluent communities, whether in the developing world or in aboriginal communities in the global North. High rates of impetigo are a marker for widespread streptococcal transmission.

In the UK, there are approximately 20 cases per year, according to a BPSU surveillance study. [16]

Diagnosis

Chorea is distinctive, if the health care provider is familiar with it. The diagnosis is then made by the typical acute onset in the weeks following a sore throat or other minor infection, plus evidence of inflammation (raised CRP and/or ESR) and evidence of recent streptococcal infection.

To confirm recent streptococcal infection:

None of these tests are 100% reliable, particularly when the infection was some months previously.

Further testing is directed more towards alternative diagnoses and other manifestations of rheumatic fever:

Management

Penicillin Penicillin core.svg
Penicillin

Management of Sydenham's chorea is based on the following principles:

Treatment of chorea

Treatment with sodium valproate is effective for controlling symptoms, but it does not speed up recovery. Haloperidol was used previously, but caused serious side effects e.g. tardive dyskinesia. Case reports exist to support carbamazepine and levetiracetam; other drugs tried include pimozide, clonidine, and phenobarbitone.

Immunosuppression

Immunosuppression is used inconsistently in Sydenham's chorea. The model of an autoimmune disorder would support its use. One randomized controlled trial of steroids from Paz, Brazil in 2006 (22 cases) showed remission reduced to 54 days from 119 days. [19] Various other reports of use of oral or IV steroids from Israel, Italy and Brazil. [20] [21] [22] Immunoglobulin has been used in Holland and South Africa. [23] [24] Some improvement can be seen within a few days of IV steroids. In Italy, prednisolone reduced average duration of symptoms from 9 weeks to 4 weeks, and these were severe cases. [20] South African group found less neuropsychiatric complications at 6 months with IVIG treatment (IVIG preferred due to fear of TB reactivation). [25]

Relapse prevention

Penicillin prophylaxis is essential to treat cardiac features of rheumatic fever, even if subclinical (American Heart Association guideline). [26] If there are not features to warrant a diagnosis of rheumatic fever, it is arguable whether cardiac risk justifies prophylaxis or not; however, it is likely to reduce recurrence.

Other treatments

There are several historical case series reporting successful treatment of Sydenham's chorea by inducing fever. [27] [28]

Prognosis

Symptoms usually get worse over the course of two weeks, then stabilize, and finally begin to improve. [4] Motor problems, including chorea, settle within an average of 2–3 months. [4]

Recurrence is seen in 16–40% of cases. It is sometimes but not always associated with a rise in ASO titre or other evidence of new streptococcal infection. Recurrence is more likely with poor compliance with penicillin prophylaxis. It is more likely if there is failure to remit within 6 months of onset. Recurrence is associated in women with pregnancy (chorea gravidorum) and with female hormone treatment, although the onset of chorea can be delayed by months or more.

Intramuscular penicillin given every 2–3 weeks is superior to a 4 weekly regime for preventing relapse, but a risk assessment may conclude that twice daily oral penicillin is sufficiently effective, less painful for the child, and less demanding on the family.

Higher recurrence rates are seen with the longest follow up – relapse can be seen 10 years or more after the initial episode, so might be underestimated by series with shorter follow up.

Recurrence is usually only chorea, even if the original case was associated with rheumatic fever. There are two total reports of heart disease worsening after recurrence of chorea. The Thailand study also had 2 cases where carditis, which had improved after initial diagnosis, came back again. Some suggest that recurrent chorea is a different disease altogether. [29]

10% reported long-term tremor in one study (10 years follow up). Long term neuropsychiatric difficulties are increasingly recognized (49 studies so far, especially obsessive-compulsive disorder but also attention-deficit hyperactivity disorder, affective disorders, tic disorders, executive function disturbances, psychotic features, and language impairment). [30]

Heart involvement improves in about a third of cases (whether silent or not). [31]

History

The incidence of acute rheumatic fever and rheumatic heart disease is not declining. Recent figures quote the incidence of Acute Rheumatic Fever as 0.6–0.7/1,000 population in the United States and Japan compared with 15–21/1,000 population in Asia and Africa. [32] The prevalence of Acute Rheumatic Fever and Sydenham's Chorea has declined progressively in developed countries over the last decades. [33] [34]

Etymology

It is named after British physician Thomas Sydenham (1624–1689). [32] [35] The alternate eponym, "Saint Vitus Dance", is in reference to Saint Vitus, a Christian saint who was persecuted by Roman emperors and died as a martyr in AD 303. Saint Vitus is considered to be the patron saint of dancers, with the eponym given as homage to the manic dancing that historically took place in front of his statue during the feast of Saint Vitus in Germanic and Latvian cultures. [36]

Related Research Articles

<span class="mw-page-title-main">Group A streptococcal infection</span> Medical condition

Group A streptococcal infections are a number of infections with Streptococcus pyogenes, a group A streptococcus (GAS). S. pyogenes is a species of beta-hemolytic Gram-positive bacteria that is responsible for a wide range of infections that are mostly common and fairly mild. If the bacteria enter the bloodstream an infection can become severe and life-threatening, and is called an invasive GAS (iGAS).

<span class="mw-page-title-main">Scarlet fever</span> Infectious disease caused by Streptococcus pyogenes

Scarlet fever, also known as scarlatina, is an infectious disease caused by Streptococcus pyogenes, a Group A streptococcus (GAS). It most commonly affects children between five and 15 years of age. The signs and symptoms include a sore throat, fever, headache, swollen lymph nodes, and a characteristic rash. The face is flushed and the rash is red and blanching. It typically feels like sandpaper and the tongue may be red and bumpy. The rash occurs as a result of capillary damage by exotoxins produced by S.pyogenes. On darker-pigmented skin the rash may be hard to discern.

<span class="mw-page-title-main">Streptococcal pharyngitis</span> Medical condition

Streptococcal pharyngitis, also known as streptococcal sore throat, is pharyngitis caused by Streptococcus pyogenes, a gram-positive, group A streptococcus. Common symptoms include fever, sore throat, red tonsils, and enlarged lymph nodes in the front of the neck. A headache and nausea or vomiting may also occur. Some develop a sandpaper-like rash which is known as scarlet fever. Symptoms typically begin one to three days after exposure and last seven to ten days.

Myelitis is inflammation of the spinal cord which can disrupt the normal responses from the brain to the rest of the body, and from the rest of the body to the brain. Inflammation in the spinal cord can cause the myelin and axon to be damaged resulting in symptoms such as paralysis and sensory loss. Myelitis is classified to several categories depending on the area or the cause of the lesion; however, any inflammatory attack on the spinal cord is often referred to as transverse myelitis.

<span class="mw-page-title-main">Pharyngitis</span> Inflammation of the back of the throat

Pharyngitis is inflammation of the back of the throat, known as the pharynx. It typically results in a sore throat and fever. Other symptoms may include a runny nose, cough, headache, difficulty swallowing, swollen lymph nodes, and a hoarse voice. Symptoms usually last 3–5 days, but can be longer depending on cause. Complications can include sinusitis and acute otitis media. Pharyngitis is a type of upper respiratory tract infection.

<span class="mw-page-title-main">Rheumatic fever</span> Post-streptococcal inflammatory disease

Rheumatic fever (RF) is an inflammatory disease that can involve the heart, joints, skin, and brain. The disease typically develops two to four weeks after a streptococcal throat infection. Signs and symptoms include fever, multiple painful joints, involuntary muscle movements, and occasionally a characteristic non-itchy rash known as erythema marginatum. The heart is involved in about half of the cases. Damage to the heart valves, known as rheumatic heart disease (RHD), usually occurs after repeated attacks but can sometimes occur after one. The damaged valves may result in heart failure, atrial fibrillation and infection of the valves.

Chorea is an abnormal involuntary movement disorder, one of a group of neurological disorders called dyskinesias. The term chorea is derived from the Ancient Greek: χορεία, as the quick movements of the feet or hands are comparable to dancing.

<span class="mw-page-title-main">Tonsillitis</span> Inflammation of the tonsils

Tonsillitis is inflammation of the tonsils in the upper part of the throat. It can be acute or chronic. Acute tonsillitis typically has a rapid onset. Symptoms may include sore throat, fever, enlargement of the tonsils, trouble swallowing, and enlarged lymph nodes around the neck. Complications include peritonsillar abscess (Quinsy).

Dyskinesia refers to a category of movement disorders that are characterized by involuntary muscle movements, including movements similar to tics or chorea and diminished voluntary movements. Dyskinesia can be anything from a slight tremor of the hands to an uncontrollable movement of the upper body or lower extremities. Discoordination can also occur internally especially with the respiratory muscles and it often goes unrecognized. Dyskinesia is a symptom of several medical disorders that are distinguished by their underlying cause.

<span class="mw-page-title-main">Kawasaki disease</span> Disease found in young children

Kawasaki disease is a syndrome of unknown cause that results in a fever and mainly affects children under 5 years of age. It is a form of vasculitis, where medium-sized blood vessels become inflamed throughout the body. The fever typically lasts for more than five days and is not affected by usual medications. Other common symptoms include large lymph nodes in the neck, a rash in the genital area, lips, palms, or soles of the feet, and red eyes. Within three weeks of the onset, the skin from the hands and feet may peel, after which recovery typically occurs. The disease is the leading cause of acquired heart disease in children in developed countries, which include the formation of coronary artery aneurysms and myocarditis.

<span class="mw-page-title-main">Erythema marginatum</span> Medical condition

Erythema marginatum is an acquired skin condition which primarily affects the arms, trunk, and legs. It is a type of erythema characterised by bright pink or red circular lesions which have sharply-defined borders and faint central clearing. The lesions typically range from 3 to 10 cm in size, and are distributed symmetrically over the torso and inner surfaces of the limbs and extensor surfaces. The lesions last between one and four weeks but have been known to be present on patients for as long as several months.

A complication in medicine, or medical complication, is an unfavorable result of a disease, health condition, or treatment. Complications may adversely affect the prognosis, or outcome, of a disease. Complications generally involve a worsening in the severity of the disease or the development of new signs, symptoms, or pathological changes that may become widespread throughout the body and affect other organ systems. Thus, complications may lead to the development of new diseases resulting from previously existing diseases. Complications may also arise as a result of various treatments.

<span class="mw-page-title-main">PANDAS</span> Hypothesis in pediatric medicine

Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) is a controversial hypothetical diagnosis for a subset of children with rapid onset of obsessive-compulsive disorder (OCD) or tic disorders. Symptoms are proposed to be caused by group A streptococcal (GAS), and more specifically, group A beta-hemolytic streptococcal (GABHS) infections. OCD and tic disorders are hypothesized to arise in a subset of children as a result of a post-streptococcal autoimmune process. The proposed link between infection and these disorders is that an autoimmune reaction to infection produces antibodies that interfere with basal ganglia function, causing symptom exacerbations, and this autoimmune response results in a broad range of neuropsychiatric symptoms.

<span class="mw-page-title-main">Neurosyphilis</span> Infection of the central nervous system in a patient with syphilis

Neurosyphilis is the infection of the central nervous system in a patient with syphilis. In the era of modern antibiotics, the majority of neurosyphilis cases have been reported in HIV-infected patients. Meningitis is the most common neurological presentation in early syphilis. Tertiary syphilis symptoms are exclusively neurosyphilis, though neurosyphilis may occur at any stage of infection.

Causes and origins of Tourette syndrome have not been fully elucidated. Tourette syndrome is an inherited neurodevelopmental disorder that begins in childhood or adolescence, characterized by the presence of multiple motor tics and at least one phonic tic, which characteristically wax and wane. Tourette's syndrome occurs along a spectrum of tic disorders, which includes transient tics and chronic tics.

Chorea gravidarum is a rare type of chorea which presents with involuntary abnormal movement, characterized by abrupt, brief, nonrhythmic, nonrepetitive movement of any limb, often associated with nonpatterned facial grimaces. It is a complication of pregnancy which can be associated with eclampsia and its effects upon the basal ganglia. It is not a causal or pathologically distinct entity but a generic term for chorea of any cause starting during pregnancy. It is associated with history of Sydenham's chorea. It mostly occurs in young patients; the average age is 22 years.

Neuroborreliosis is a disorder of the central nervous system. A neurological manifestation of Lyme disease, neuroborreliosis is caused by a systemic infection of spirochetes of the genus Borrelia. Symptoms of the disease include erythema migrans and flu-like symptoms.

<span class="mw-page-title-main">Basal ganglia disease</span> Group of physical problems resulting from basal ganglia dysfunction

Basal ganglia disease is a group of physical problems that occur when the group of nuclei in the brain known as the basal ganglia fail to properly suppress unwanted movements or to properly prime upper motor neuron circuits to initiate motor function. Research indicates that increased output of the basal ganglia inhibits thalamocortical projection neurons. Proper activation or deactivation of these neurons is an integral component for proper movement. If something causes too much basal ganglia output, then the ventral anterior (VA) and ventral lateral (VL) thalamocortical projection neurons become too inhibited, and one cannot initiate voluntary movement. These disorders are known as hypokinetic disorders. However, a disorder leading to abnormally low output of the basal ganglia leads to reduced inhibition, and thus excitation, of the thalamocortical projection neurons which synapse onto the cortex. This situation leads to an inability to suppress unwanted movements. These disorders are known as hyperkinetic disorders.

Perianal cellulitis, also known as perianitis or perianal streptococcal dermatitis, is a bacterial infection affecting the lower layers of the skin (cellulitis) around the anus. It presents as bright redness in the skin and can be accompanied by pain, difficulty defecating, itching, and bleeding. This disease is considered a complicated skin and soft tissue infection (cSSTI) because of the involvement of the deeper soft tissues.

<span class="mw-page-title-main">Autoimmune encephalitis</span> Type of encephalitis

Autoimmune encephalitis (AIE) is a type of encephalitis, and one of the most common causes of noninfectious encephalitis. It can be triggered by tumors, infections, or it may be cryptogenic. The neurological manifestations can be either acute or subacute and usually develop within six weeks. The clinical manifestations include behavioral and psychiatric symptoms, autonomic disturbances, movement disorders, and seizures.

References

  1. ↑ "Sydenham Chorea Information Page | National Institute of Neurological Disorders and Stroke". www.ninds.nih.gov. Retrieved 2 March 2021.
  2. ↑ Maia, Débora P.; Fonseca, Patricia G.; Camargos, Sarah T.; Pfannes, Cláudia; Cunningham, Mauro C.; Cardoso, Francisco (June 2012). "Pregnancy in patients with Sydenham's Chorea". Parkinsonism & Related Disorders. 18 (5): 458–461. doi:10.1016/j.parkreldis.2011.12.013. PMID   22236583.
  3. ↑ Kyle, Kevin; Bordelon, Yvette; Venna, Nagagopal; Linnoila, Jenny (18 March 2022). "Autoimmune and Paraneoplastic Chorea: A Review of the Literature". Frontiers in Neurology. 13. doi: 10.3389/fneur.2022.829076 . PMC   8972589 . PMID   35370928.
  4. 1 2 3 4 5 6 Mosby's Medical Dictionary. Elsevier Health Sciences. 2021-07-23. p. 1735. ISBN   978-0-323-83162-8.
  5. ↑ Verma, Anoop; Kunju, P. A. M. (2019-05-31). IAP Textbook of Pediatric Neurology. Jaypee Brothers Medical Publishers. p. 354. ISBN   978-93-5270-979-3.
  6. ↑ Talley, Nicholas J.; O’Connor, Simon (2020-10-30). Talley and O'Connor's Examination Medicine - epub: A Guide to Physician Training. Elsevier Health Sciences. p. 577. ISBN   978-0-7295-8875-1.
  7. ↑ Oosterveer, Daniëlla M.; Overweg-Plandsoen, Wilhelmina C.T.; Roos, Raymund A.C. (July 2010). "Sydenham's Chorea: A Practical Overview of the Current Literature". Pediatric Neurology. 43 (1): 1–6. doi:10.1016/j.pediatrneurol.2009.11.015. PMID   20682195 . Retrieved 2 March 2021.
  8. ↑ Wilbur C, Bitnun A, Kronenberg S, Laxer RM, Levy DM, Logan WJ, Shouldice M, Yeh EA (May 2019). "PANDAS/PANS in childhood: Controversies and evidence". Paediatr Child Health. 24 (2): 85–91. doi:10.1093/pch/pxy145. PMC   6462125 . PMID   30996598.
  9. ↑ Sigra S, Hesselmark E, Bejerot S (March 2018). "Treatment of PANDAS and PANS: a systematic review". Neurosci Biobehav Rev. 86: 51–65. doi: 10.1016/j.neubiorev.2018.01.001 . PMID   29309797. S2CID   40827012.
  10. ↑ Swedo SE, Leonard HL, Garvey M, et al. (February 1998). "Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases". The American Journal of Psychiatry. 155 (2): 264–71. doi:10.1176/ajp.155.2.264. PMID   9464208. S2CID   22081877.
  11. ↑ Zomorrodi A, Wald ER (2006). "Sydenham's Chorea in Western Pennsylvania". Pediatrics. 117 (4): 675–679. doi:10.1542/peds.2005-1573. PMID   16533893. S2CID   32478765.
  12. ↑ Swedo SE, Leonard HL, Shapiro MB (1993). "Sydenham's Chorea:Physical and Psychological Symptoms of St Vitus Dance". Pediatrics. 91 (4): 706–713. PMID   8464654.
  13. ↑ Cunningham, Madeleine W. (2 August 2019). "Molecular Mimicry, Autoimmunity, and Infection: The Cross-Reactive Antigens of Group A Streptococci and their Sequelae". Microbiology Spectrum. 7 (4). doi:10.1128/microbiolspec.GPP3-0045-2018. PMC   6684244 . PMID   31373269.
  14. ↑ Dale RC, Merheb V, Pillai S, et al. (2012). "Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders". Brain. 135 (11): 3453–3468. doi: 10.1093/brain/aws256 . PMID   23065479.
  15. ↑ Ben-Pazi H, Stoner JA, Cunningham MW (2013). "Dopamine receptor autoantibodies correlate with symptoms in Sydenham's chorea". PLOS ONE. 8 (9): e73516. Bibcode:2013PLoSO...873516B. doi: 10.1371/journal.pone.0073516 . PMC   3779221 . PMID   24073196.
  16. ↑ Wooding, Eva Louise; Morton, Michael John Stuart; Lim, Ming; Mitrofan, Oana; Mushet, Nadine; Sie, Adrian; Knight, Brodie; Ford, Tamsin; Newlove-Delgado, Tamsin (September 2023). "Childhood/adolescent Sydenham's chorea in the UK and Ireland: a BPSU/CAPSS surveillance study". Archives of Disease in Childhood. 108 (9): 736–741. doi:10.1136/archdischild-2023-325399. PMC   10447407 . PMID   37225279.
  17. ↑ "Sydenham chorea: MedlinePlus Medical Encyclopedia".
  18. ↑ Faustino PC, Terreri MT, Rocha AJ, et al. (2003). "Clinical, laboratory, psychiatric and magnetic resonance findings in patients with sydenham chorea". Neuroradiology. 45 (7): 456–462. doi:10.1007/s00234-003-0999-8. PMID   12811441. S2CID   23605799.
  19. ↑ Paz, José A.; Silva, Clovis A.A.; Marques-Dias, Maria J. (April 2006). "Randomized Double-Blind Study With Prednisone in Sydenham's Chorea". Pediatric Neurology. 34 (4): 264–269. doi:10.1016/j.pediatrneurol.2005.08.028. PMID   16638499.
  20. 1 2 Fusco, Carlo; Ucchino, Valentina; Frattini, Daniele; Pisani, Francesco; Della Giustina, Elvio (July 2012). "Acute and chronic corticosteroid treatment of ten patients with paralytic form of Sydenham's chorea". European Journal of Paediatric Neurology. 16 (4): 373–378. doi:10.1016/j.ejpn.2011.12.005. PMID   22197452.
  21. ↑ Fusco, C.; Spagnoli, C. (March 2018). "Corticosteroid treatment in Sydenham's chorea". European Journal of Paediatric Neurology. 22 (2): 327–331. doi:10.1016/j.ejpn.2017.11.011. PMID   29287833.
  22. ↑ Teixeira Jr., Antônio L.; Maia, Débora P.; Cardoso, Francisco (August 2005). "Treatment of acute Sydenham's chorea with methyl-prednisolone pulse-therapy". Parkinsonism & Related Disorders. 11 (5): 327–330. doi:10.1016/j.parkreldis.2005.02.007. PMID   15878690.
  23. ↑ Boersma, Nienke Anne; Schippers, Herman; Kuijpers, Taco; Heidema, Jojanneke (27 January 2016). "Successful treatment of Sydenham's chorea with intravenous immunoglobulin". BMJ Case Reports. 2016: bcr2015211673. doi:10.1136/bcr-2015-211673. PMC   4746543 . PMID   26837939.
  24. ↑ Gregorowski, Claire; Lochner, Christine; Martin, Lindi; Simmons, Candice; Kidd, Martin; Walker, Kathleen; Wilmshurst, Jo M.; Seedat, Soraya (1 February 2016). "Neuropsychological manifestations in children with Sydenham's chorea after adjunct intravenous immunoglobulin and standard treatment". Metabolic Brain Disease. 31 (1): 205–212. doi:10.1007/s11011-015-9681-1. PMID   25987537. S2CID   3234882.
  25. ↑ Dean, Shannon L.; Singer, Harvey S. (1 June 2017). "Treatment of Sydenham's Chorea: A Review of the Current Evidence". Tremor and Other Hyperkinetic Movements. 7: 456. doi:10.7916/d8w95gj2. PMC   5459984 . PMID   28589057.
  26. ↑ Kumar, Raman Krishna; Antunes, Manuel J.; Beaton, Andrea; Mirabel, Mariana; Nkomo, Vuyisile T.; Okello, Emmy; Regmi, Prakash Raj; Reményi, Boglarka; Sliwa-Hähnle, Karen; Zühlke, Liesl Joanna; Sable, Craig; American Heart Association Council on Lifelong Congenital Heart Disease Heart Health in the Young; Council on Cardiovascular Stroke Nursing; Council on Clinical Cardiology (17 November 2020). "Contemporary Diagnosis and Management of Rheumatic Heart Disease: Implications for Closing the Gap: A Scientific Statement From the American Heart Association". Circulation. 142 (20): e337–e357. doi: 10.1161/CIR.0000000000000921 . PMID   33073615. S2CID   224783747.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  27. ↑ Sutton, LP; Dodge, KG (1933). "The treatment of chorea by induced fever". The Journal of Pediatrics. 3 (6): 813–26. doi:10.1016/s0022-3476(33)80151-x.
  28. ↑ Sutton, LP; Dodge, KG (1936). "Fever therapy in chorea and in rheumatic carditis with and without chorea". The Journal of Laboratory and Clinical Medicine. 21 (6): 619–28.
  29. ↑ Gurkas, E; Karalok, ZS; Taskin, BD; Aydogmus, U; Guven, A; Degerliyurt, A; Bektas, O; Yilmaz, C (October 2016). "Predictors of recurrence in Sydenham's chorea: Clinical observation from a single center". Brain & Development. 38 (9): 827–34. doi:10.1016/j.braindev.2016.04.010. PMID   27209549. S2CID   2614986.
  30. ↑ Punukollu, M; Mushet, N; Linney, M; Hennessy, C; Morton, M (January 2016). "Neuropsychiatric manifestations of Sydenham's chorea: a systematic review". Developmental Medicine and Child Neurology. 58 (1): 16–28. doi: 10.1111/dmcn.12786 . PMID   25926089. S2CID   31037155.
  31. ↑ Ekici, Filiz; Cetin, Ibrahim Ilker; Cevik, Berna-Saylan; Senkon, Oben Gözde; Alpan, Nursel; Değerliyurt, Aydan; Güven, Alev; Ateş, Can; Cakar, Nilgün (March 2012). "What is the outcome of rheumatic carditis in children with Sydenham's chorea?". The Turkish Journal of Pediatrics. 54 (2): 159–167. ISSN   0041-4301. PMID   22734303.
  32. 1 2 Walker K, Lawrenson J, Wilmshurst JM (2006). "Sydenham's Chorea-clinical and therapeutic update 320 years down the line". South African Medical Journal. 96 (9): 906–912. PMID   17077917.
  33. ↑ Nausieda PA, Grossman BJ, Koller WC, et al. (1980). "Sydenham's Chorea:An update". Neurology. 30 (3): 331–334. doi:10.1212/wnl.30.3.331. PMID   7189038. S2CID   21035716.
  34. ↑ Eshel E, Lahat E, Azizi E, et al. (1993). "Chorea as a manifestation of rheumatic fever-a 30-year survey". European Journal of Pediatrics. 152 (8): 645–646. doi:10.1007/bf01955239. PMID   8404967. S2CID   29611352.
  35. ↑ "Sydenham's chorea". Whonamedit. Retrieved 2011-09-16.
  36. ↑ "St. Vitus Information Page - Star Quest Production Network". Saints.sqpn.com. 2009-01-07. Retrieved 2011-09-16.

Further reading

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.